Praveen Tyle insider trades

Open-market stock purchases and sales by Praveen Tyle, Director at Kiora Pharmaceuticals Inc, from SEC Form 4 filings since Feb 19, 2015.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -41%.

Recent trades

DateStockTradeValue
Jun 10, 2026KPRX Kiora Pharmaceuticals IncBought (not open market)—

Companies traded

  • KPRX Kiora Pharmaceuticals Inc: 1 buy, last Jun 10, 2026
  • SKYE Skye Bioscience, Inc: other filings, last Feb 29, 2024
  • LXRX Lexicon Pharmaceuticals, Inc: other filings, last Feb 28, 2021
  • EYEG Eyegate Pharmaceuticals Inc: other filings, last Feb 1, 2021

Get free alerts when Praveen Tyle files a new trade →